# Stoke Therapeutics, Inc.: filings

STOK · Nasdaq · CIK 1623526 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stok.md) · [Financials](/companies/stok/financials.md) · [Filings](/companies/stok/filings.md) · [Insiders](/companies/stok/insiders.md)

## Reports and events: 137 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 275, 8-K 85, 144 48, 3 25, 10-Q 22, SC 13G/A 22, SCHEDULE 13G/A 16, CORRESP 11, S-8 11, SC 13G 11, UPLOAD 9, DEF 14A 8, DEFA14A 8, 10-K 7, 424B5 5, EFFECT 5, ARS 4, S-3 4, SC 13D/A 4, SCHEDULE 13D/A 4, SCHEDULE 13G 4, 4/A 3, SC TO-I/A 3, D 2, DRS 2, DRSLTR 2, PRE 14A 2, S-1/A 2, S-3ASR 2, SC 13D 2, SEC STAFF LETTER 2, 10-Q/A 1, 3/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS/A 1, FWP 1, S-1 1, S-1MEF 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:05 ET | [8-K](/filings/0001193125-26-437775.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-437775 |
| 2026-09-25 | 16:05 ET | [8-K](/filings/0001193125-26-402820.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-402820 |
| 2026-08-03 | 17:06 ET | [8-K](/filings/0001193125-26-330804.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-330804 |
| 2026-08-03 | 16:07 ET | [10-Q](/filings/0001193125-26-330557.md) | Quarterly report, period 2026-06-30 | 0001193125-26-330557 |
| 2026-08-03 | 16:05 ET | [8-K](/filings/0001193125-26-330537.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-330537 |
| 2026-06-30 | 08:02 ET | [8-K](/filings/0001193125-26-289409.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-289409 |
| 2026-06-04 | 16:08 ET | [8-K](/filings/0001193125-26-257394.md) | 5.07 Shareholder vote results | 0001193125-26-257394 |
| 2026-05-07 | 16:19 ET | [8-K](/filings/0001193125-26-212020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-212020 |
| 2026-05-07 | 16:06 ET | [10-Q](/filings/0001193125-26-211874.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211874 |
| 2026-04-22 | 16:05 ET | [DEF 14A](/filings/0001193125-26-170362.md) | Proxy statement, period 2026-06-03 | 0001193125-26-170362 |
| 2026-04-07 | 16:05 ET | [8-K](/filings/0001193125-26-145524.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-145524 |
| 2026-03-27 | 16:30 ET | [8-K](/filings/0001193125-26-129168.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-129168 |
| 2026-03-16 | 16:15 ET | [10-K](/filings/0001193125-26-108362.md) | Annual report, period 2025-12-31 | 0001193125-26-108362 |
| 2026-03-03 | 16:11 ET | [8-K](/filings/0001193125-26-088205.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-088205 |
| 2026-01-26 | 16:06 ET | [8-K](/filings/0001193125-26-022569.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-26-022569 |
| 2026-01-12 | 07:34 ET | [8-K](/filings/0001193125-26-009781.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009781 |
| 2025-12-05 | 09:05 ET | [8-K](/filings/0001193125-25-308781.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-308781 |
| 2025-11-04 | 16:16 ET | [10-Q](/filings/0001193125-25-264720.md) | Quarterly report, period 2025-09-30 | 0001193125-25-264720 |
| 2025-11-04 | 16:05 ET | [8-K](/filings/0001193125-25-264644.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-264644 |
| 2025-10-06 | 07:30 ET | [8-K](/filings/0001193125-25-230925.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-230925 |
| 2025-09-18 | 16:07 ET | [8-K/A](/filings/0001193125-25-207401.md) | 5.07 Shareholder vote results | 0001193125-25-207401 |
| 2025-08-26 | 17:42 ET | [SCHEDULE 13D/A](/filings/0001123292-25-000387.md) | Ownership report, active investor, amended | 0001123292-25-000387 |
| 2025-08-12 | 16:16 ET | [10-Q](/filings/0000950170-25-107332.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107332 |
| 2025-08-12 | 16:01 ET | [8-K](/filings/0000950170-25-107275.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-107275 |
| 2025-08-11 | 07:00 ET | [8-K](/filings/0001193125-25-177433.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-177433 |
| 2025-07-10 | 07:00 ET | [8-K](/filings/0001193125-25-157364.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-157364 |
| 2025-06-23 | 16:47 ET | [SCHEDULE 13D/A](/filings/0001123292-25-000298.md) | Ownership report, active investor, amended | 0001123292-25-000298 |
| 2025-06-06 | 16:23 ET | [SCHEDULE 13D/A](/filings/0001123292-25-000272.md) | Ownership report, active investor, amended | 0001123292-25-000272 |
| 2025-06-04 | 16:05 ET | [8-K](/filings/0001193125-25-134882.md) | 5.07 Shareholder vote results | 0001193125-25-134882 |
| 2025-06-04 | 07:00 ET | [8-K](/filings/0001193125-25-134447.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-134447 |
| 2025-05-13 | 16:05 ET | [10-Q](/filings/0000950170-25-070296.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070296 |
| 2025-05-13 | 07:05 ET | [8-K](/filings/0000950170-25-069783.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069783 |
| 2025-04-22 | 16:05 ET | [DEF 14A](/filings/0001193125-25-089188.md) | Proxy statement, period 2025-06-03 | 0001193125-25-089188 |
| 2025-03-18 | 16:05 ET | [10-K](/filings/0000950170-25-041170.md) | Annual report, period 2024-12-31 | 0000950170-25-041170 |
| 2025-03-18 | 07:05 ET | [8-K](/filings/0000950170-25-040758.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-040758 |
| 2025-02-18 | 16:31 ET | [8-K](/filings/0001193125-25-028650.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028650 |
| 2025-01-07 | 07:06 ET | [8-K](/filings/0001193125-25-002550.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-002550 |
| 2024-12-27 | 17:23 ET | [SCHEDULE 13D/A](/filings/0001123292-24-000417.md) | Ownership report, active investor, amended | 0001123292-24-000417 |
| 2024-12-06 | 17:19 ET | [8-K](/filings/0001193125-24-272559.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-272559 |
| 2024-11-05 | 16:05 ET | [10-Q](/filings/0000950170-24-121445.md) | Quarterly report, period 2024-09-30 | 0000950170-24-121445 |
| 2024-11-05 | 07:05 ET | [8-K](/filings/0000950170-24-121068.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-121068 |
| 2024-09-23 | 16:22 ET | [SC 13D/A](/filings/0001123292-24-000282.md) | Ownership report, active investor, amended | 0001123292-24-000282 |
| 2024-09-10 | 16:17 ET | [8-K](/filings/0001193125-24-216632.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-216632 |
| 2024-08-07 | 16:05 ET | [10-Q](/filings/0000950170-24-092738.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092738 |
| 2024-08-07 | 07:05 ET | [8-K](/filings/0000950170-24-092268.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092268 |
| 2024-06-21 | 16:05 ET | [8-K](/filings/0001193125-24-165651.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-165651 |
| 2024-06-06 | 16:06 ET | [8-K](/filings/0001193125-24-156049.md) | 5.07 Shareholder vote results | 0001193125-24-156049 |
| 2024-05-06 | 16:05 ET | [10-Q](/filings/0000950170-24-053535.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053535 |
| 2024-05-06 | 07:05 ET | [8-K](/filings/0000950170-24-053195.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053195 |
| 2024-04-29 | 16:05 ET | [8-K](/filings/0001193125-24-122215.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-122215 |

Page 1 of 3. [Older](/companies/stok/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:06 ET. No prices; not investment advice.